Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsReiterationPrice Target
Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.
Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.